2025 Oncology Institute
April 25, 2025 | 3:35 PM EST
- Home
- Clinical Resources Search
- PQI: Exercise During Cancer Treatment
Exercise During Cancer Treatment
About this PQI
Not only does exercise during cancer treatment decrease the number and/or severity of side effects, but it also assists in recovery from treatment and in some cases can lower the risk of cancer recurrence. Exercise is also vital for the maintenance and/or improvement of physical functioning, mental health, and quality of life during treatment. Per guidelines, it is recommended that all individuals diagnosed with cancer avoid inactivity, improve general health, and aim to achieve the current physical activity guidelines for healthy populations (≥150 min/week aerobic exercise and ≥2 days/week strength training as well as incorporating balance and flexibility exercise).1,2,3 This is why it is vital that these individuals are working with proper exercise professionals to ensure that they are getting the appropriate modes and intensities of exercise to best help them meet those recommendations. If individuals are unable to meet recommended targets upon starting exercise, the appropriately qualified exercise professionals would assist them to meet these recommendations.

How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Epcoritamab (epcoritamab-bysp) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
Author: Syed Zia Khan, PharmD, BCSCP
Last Updated: 04/25/2025
PQI: Ibrutinib Dosing Optimization
Author: Nick Bouchard, PharmD | Danielle Maciorowski, PharmD
Last Updated: 04/25/2025
PQI: Zanubrutinib (Brukinsa®) Patient Selection and Management
Author: Kayla Randle, PharmD, BCOP
Last Updated: 04/25/2025
PQI: Zanubrutinib (Brukinsa ®) treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Author: Kirollos Hanna, PharmD, BCPS, BCOP, FACCC, FAPO
Last Updated: 04/25/2025
PQI in Action
PQI in Action
PQI in Action
PQI in Action
PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management
Author: Scripps Health, CA | UPMC, PA
Last Updated: 04/25/2025
PQI in Action: Tepotinib (Tepmetko®) for Non-Small Cell Lung Cancerwith MET Exon 14 Alterations
Author: Florida Cancer Specialists & Research Institute, FL | Mayo Clinic, MN | Texas Oncology, TX
Last Updated: 04/25/2025
PQI in Action: Siltuximab (Sylvant®) in Patients with Idiopathic Multicentric Castleman Disease
Author: University of Michigan Health-Sparrow Herbert-Herman Cancer Center, MI | Texas Oncology, TX | University of North Carolina (UNC) Health, NC
Last Updated: 04/25/2025
PQI in Action: Isatuximab-irfc (Sarclisa®) in 1q21 Gain or Amplifications in Relapsed/Refractory Multiple Myeloma
Author: Texas Oncology, TX | Florida Cancer Specialists & Research Institute, FL | University Hospitals Cleveland Medical Center, OH
Last Updated: 04/25/2025
PQI Podcast
PQI Podcast
PQI Podcast
PQI Podcast
The PQI Podcast S8 Ep 11: Honoring Her Legacy: A Conversation with Miss America 2024
Author: Ginger Blackmon, PharmD | Madison Marsh
Last Updated: 04/25/2025
The PQI Podcast S8 Ep 10: Operationalizing Bispecifics in the Community Setting
Author: Ginger Blackmon, PharmD | Nick Bouchard, PharmD
Last Updated: 04/25/2025
The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program
Author: Ginger Blackmon, PharmD | Salvatore Bottiglieri, PharmD, BCOP
Last Updated: 04/25/2025
The PQI Podcast S3 Ep 12: Health Disparities in Cancer Screenings
Author: Ginger Blackmon, PharmD | Shana O. Ntiri, MD, MPH, FAAFP,
Last Updated: 04/25/2025
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit: Abemaciclib
Last Updated: 04/25/2025
Treatment Support Kit: Temozolomide
Last Updated: 04/25/2025
Treatment Support Kit: Tivozanib
Last Updated: 04/25/2025
Treatment Support Kit: Regorafenib
Last Updated: 04/25/2025
Video
Video
Video
Video
Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide
Last Updated: 04/25/2025
Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma
Author: Brad Kahl, MD
Last Updated: 04/25/2025
Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications
Author: Jo Ellen Rodgers, PharmD, BCPS, BCCP
Last Updated: 04/25/2025
Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)
Author: Joyce O’Shaughnessy, MD
Last Updated: 04/25/2025
PQI Podcast
PQI Podcast
PQI Podcast
PQI Podcast
The PQI Podcast S8 Ep 10: Operationalizing Bispecifics in the Community Setting
Author: Ginger Blackmon, PharmD | Nick Bouchard, PharmD
Last Updated: 04/25/2025
The PQI Podcast S3 Ep 11: Moffitt Clinical Pharmacy Program
Author: Ginger Blackmon, PharmD | Salvatore Bottiglieri, PharmD, BCOP
Last Updated: 04/25/2025
The PQI Podcast S3 Ep 12: Health Disparities in Cancer Screenings
Author: Ginger Blackmon, PharmD | Shana O. Ntiri, MD, MPH, FAAFP,
Last Updated: 04/25/2025
The PQI Podcast S3 Ep 13: The Importance of the Multidisciplinary Team
Author: Ginger Blackmon, PharmD | April Hallatt, BSN, RN, OCN
Last Updated: 04/25/2025
PQI Podcast
PQI Podcast
PQI Podcast
PQI Podcast
The PQI Podcast S4 Ep 5: Role of Oncology Social Worker
Author: Ginger Blackmon, PharmD | Neshama Marcus, LMSW
Last Updated: 04/25/2025
The PQI Podcast S4 Ep 6 : Community Pharmacy and Ohio Board of Pharmacy
Author: Ginger Blackmon, PharmD | Christine Pfaff, RPh
Last Updated: 04/25/2025
The PQI Podcast S4 Ep 9: Mental Illness and Burnout
Author: Ginger Blackmon, PharmD | Kyle Bradford Jones, MD, FAAFP
Last Updated: 04/25/2025
The PQI Podcast S4 Ep 10: Oncology Wellness & Exercise
Author: Ginger Blackmon, PharmD | Sami Mansfield
Last Updated: 04/25/2025
PQI Podcast
PQI
PQI in Action
PQI Podcast
The PQI Podcast S8 Ep 11: Honoring Her Legacy: A Conversation with Miss America 2024
Author: Ginger Blackmon, PharmD | Madison Marsh
Last Updated: 04/25/2025
PQI: Epcoritamab (epcoritamab-bysp) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
Author: Syed Zia Khan, PharmD, BCSCP
Last Updated: 04/25/2025
PQI in Action: Tremelimumab-actl (Imjudo®) Patient Management
Author: Scripps Health, CA | UPMC, PA
Last Updated: 04/25/2025
The PQI Podcast S8 Ep 10: Operationalizing Bispecifics in the Community Setting
Author: Ginger Blackmon, PharmD | Nick Bouchard, PharmD
Last Updated: 04/25/2025